Voltaren Arthritis Pain, a non-steroidal anti-inflammatory topical gel, has been approved for over-the-counter sales by the U.S. Food and Drug Administration. The drug is the first prescription ...

WARREN, N.J., May 3, 2021 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK), the makers of Voltaren Arthritis ... to break down and wear away, resulting in joint pain and stiffness.

Warren-based GlaxoSmithKline announced on Monday the U.S. Food and Drug Administration (FDA) approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1 percent arthritis pain reliever ...

Dr. Reddy’s is offering over-the-counter diclofenac sodium topical gel 1%, the store brand version of GSK Consumer Healthcare's Voltaren Arthritis Pain. “The launch of Dr. Reddy’s diclofenac ...

- Voltaren Arthritis Pain will donate 100 percent of pre-order profits up to $100,000 to the Arthritis Foundation's scientific research and virtual patient support WARREN, N.J., April 13, 2020 ...

WASHINGTON The Food and Drug Administration’s Division of Anesthesia, Analgesia and Rheumatology Products has approved Voltaren Gel 1 percent for the relief of the pain of osteoarthritis of ...

The makers of Voltaren pain gels have been fined $4.5 million for falsely passing a product off as being more effective in relieving arthritis symptoms. Osteo Gel and Emulgen both have the same ...